Preparation containing a contrast agent, and method for the production thereof
AT521001A1
Manufacturing process for a contrast agent
US2017087249A1
Photodynamic therapy, formulation usable for this purpose, and method for the production and use thereof
US2017087256A1
Photodynamic diagnosis, formulations usable as photosensitizers for this purpose, method for the production and use thereof
AT516104A1
Process for preparing a liquid pharmaceutical preparation
US2010249423A1
Tolperisone controlled release tablet
AT507256A1
Use of galanthaminium bromide for the manufacture of ophthalmic formulations for glaucoma treatment
AT507039A1
Method for producing high-purity benzazepine derivatives
AT505225A1
Tolperisone and their pharmaceutical acceptable salts and hydrates production for use as active substance in pharmaceutical formulation for drugs, for treatment and therapy of Alzheimer's disease, involves converting methylpropiophenone
MX2008013437A
Method for administering tolperisone.
AT504663A4
Process for the production of high purses 4a, 5,9,10,11,12, -hexahydro-6h-benzofuro (3a, 3,2-f) (2) benzazepines and their derivatives
AT502219A1
Process for representing 5-substituted tetrazoles
AT500332A2
New derivatives of (4as, 8as) -d5,6-4a, 5,9,10,11,12-hexahydro-11-methyl-3-methoxy-benzofuro (3a, 3,2-f) (2) benzazepine, process for the production and their use for the production of medicaments
MXPA06012120A
Cholinesterase inhibitors in liposomes and their production and use.
AT500999A1
Tolperisone containing veterinary medicine preparation for oral administration in the treatment of mammals, such as dogs with degenerative, spinal symptoms
AT500576A1
Process for representing crystal forms of torsemid
MXPA05005570A
Use of galanthamine and the derivatives thereof in the production of medicaments.
ATA11742004A
New derivatives of 4a, 5,9,10,11,12-hexahydro-benzofuro (3a, 3,2) (2) benzazepine, process for the production thereof and their use for the production of medicaments
AT500143A1
Cholinesterase inhibitors in liposomes and their preparation and use
AT500144A1
Tolperison-containing pharmaceutical preparation with controllable active ingredients for oral administration
